---
name: Anthea Pharma
slug: antheapharma
site: both
website_domain: antheapharma.com
summary: Anthea Pharma is an injectable CDMO in Hyderabad, India, offering development and manufacturing of vials, emulsions, lyophilized vials, and prefilled syringes. The company highlights aseptic fill and finish, terminal sterilization, lyophilization, and formulation and analytical development for clients. Headquartered in Hyderabad, India.
tagline: Injectable CDMO for vials, PFS, lyophilized vials, and emulsions
founded_year: 2019
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: IN
tier2_domain_verified: false
updated_at: 2026-10-23T07:01:18.774Z
services_count: 9
modalities_count: 0
indications_count: 0
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Anthea Pharma

Injectable CDMO for vials, PFS, lyophilized vials, and emulsions

Listed on cro.directory.

## Summary

Anthea Pharma is an injectable CDMO in Hyderabad, India, offering development and manufacturing of vials, emulsions, lyophilized vials, and prefilled syringes. The company highlights aseptic fill and finish, terminal sterilization, lyophilization, and formulation and analytical development for clients. Headquartered in Hyderabad, India.

## At a glance

- Founded: 2019
- HQ country: IN

## Services

- Formulation Development
- CMC Analytical Development
- Lyophilization (Freeze Drying)
- Vial Filling
- Sterile Fill-Finish & Aseptic Manufacturing
- Prefilled Syringe (PFS) Filling
- Technology Transfer
- Process Development
- Quality Control Testing

## Locations

- Hyderabad, Hyderabad, Telangana, India

## Long description

## Overview

Anthea Pharma Pvt. Ltd. describes itself as a young, R&D-focused injectables firm aiming to operate as a global CDMO for injectable manufacturing. Based in Hyderabad, India, and established in 2019, the company is backed by the Yashoda Group.

## Services

- Formulation and scale-up development for injectable drug products
- Lyophilization process optimization, scale-up, and technology transfer
- Method development and phase-appropriate qualification, supported by an in-house analytical development department
- Aseptic fill and finish, including vial filling and lyophilization
- Terminal sterilization for syringe and vial formats, with cycle development and validation
- Prefilled syringe and vial fill-finish capabilities
- Dispensing and compounding, using stainless steel vessels or disposable formulation technology
- On-site chemical and microbiological quality laboratories

## Products and Capabilities

The company lists liquid vials, lyophilized vials, prefilled syringes, ampoules, bags, and drops as current products, with efforts underway for peptides, long-acting injectables, suspensions, and hormonal products. Pens and cartridges are planned additions.

## Manufacturing Scale

The company reports five manufacturing lines and states an infrastructure designed to develop 30 to 40 molecules per year. Its injectable plant is described as in process of being set up.

## Quality and Operations

Formulation technicians are described as manufacturing in accordance with cGMP and global standards. Quality systems include a Manufacturing Execution System, Quality Management System, Laboratory Management System, and SAP.

## Related companies

- [CRAMSN](/companies/cramsn-research-park) (Formulation Development, CMC Analytical Development) — [Compare](/compare/antheapharma/cramsn-research-park)
- [PCI Pharma Services](/companies/pci) (Formulation Development, Lyophilization (Freeze Drying)) — [Compare](/compare/antheapharma/pci)
- [CuriRx, Inc.](/companies/curirx) (Formulation Development, CMC Analytical Development) — [Compare](/compare/antheapharma/curirx)
- [ARSI Canada Inc](/companies/arsicanada) (CMC Analytical Development, Technology Transfer) — [Compare](/compare/antheapharma/arsicanada)
- [Ardena](/companies/ardena) (Formulation Development, CMC Analytical Development) — [Compare](/compare/antheapharma/ardena)
- [Charles River Laboratories](/companies/criver) (Formulation Development, CMC Analytical Development) — [Compare](/compare/antheapharma/criver)
- [Sussex Research Laboratories Inc.](/companies/sussex-research) (CMC Analytical Development, Technology Transfer) — [Compare](/compare/antheapharma/sussex-research)
- [Scinai Immunotherapeutics Ltd.](/companies/scinai-immunotherapeutics) (CMC Analytical Development, Technology Transfer) — [Compare](/compare/antheapharma/scinai-immunotherapeutics)

_Profile last updated: 2026-10-23T07:01:18.774Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.